Skip to main content

Table 3 Responses of participants to case 2

From: An assessment for diagnostic and therapeutic modalities for management of pediatric Iron defficiency Anemia in Saudi Arabia: a crossectional study

Case #2 A previously healthy 13-year-old girl is referred to you for evaluation and treatment of anemia. She experienced menarche 2 years ago and has heavy menstrual periods. She has no evidence of a generalized bleeding disorder, and hormonal regulation has been initiated by her gynecologist. Her physical exam reveals a weight of 65 kg and mild pallor but is otherwise unremarkable. Her hemoglobin is 9.5 g/dL and MCV 65 fL. Other laboratory studies and her peripheral smear are consistent with iron deficiency. You again choose to treat with an oral iron product.

Which oral iron preparation would you recommend (Select one)?

 1

Ferrous sulphate(Fer-In-Sol®, Feromin®, Kdiron®)

76.2

 2

Ferrous fumarate (Fumafer®,Ferretts®)

7.5

 3

Ferrous gluconate (Ferrous gluconate®, Fergon®)

4.8

 4

Iron (III)- hydroxide polymaltose (Ferose-F®, Ferose®)

8.8

 5

Other (please specify)

0.7

 6

Missing

2.0

Would this patient’s daily dose be based on number of tablets daily or on weight (Select one)?

 1

Number of tablets daily

49.7

 2

Weight-based dosing

50.3

Follow-up for persons who chose number of tablets daily:

What total daily elemental iron dose would you recommend (Select one)?

 1

1 iron tablet daily

42.5

 2

2–3 iron tablets daily

53.4

 3

Other (please specify)

4.1

Follow-up for persons who choose weight-based dosing:

What total daily elemental iron dose would you recommend (Select one)?

 1

2–3 mg/kg

32.4

 2

4–5 mg/kg

58.1

 3

Other (please specify)

9.5

How would you divide the total daily iron dose (Select one)?

 1

Once daily (QDay)

28.6

 2

Divided into 2 doses (BID)

62.6

 3

Divided into 3 doses (TID)

4.8

 4

Other (please specify)

2.0

 5

Missing

2.0

Case #2 (continued) The 13 year old patient returns to your clinic 4 weeks after the initial visit. Her last several menstrual periods have been light. She reports that she took the iron medication for several days after her visit with you but then stopped it because of gastrointestinal symptoms. Her laboratory studies are similar to the previous visit. You change to another oral iron preparation, but she continues to have recurrent gastrointestinal symptoms and no improvement in her laboratory studies. You describe parenteral iron treatment options, and she is interested.

Which iron preparation would you recommend (Select one)?

 1

Intravenous iron dextran (Cosmofer®)

42.9

 2

Intravenous iron saccharate (Ferosac®)

32.7

 3

Continued oral iron therapy

14.3

 4

Other (please specify)

10.1